Rank | Gene Set | Z-score |
---|---|---|
1 | interferon-gamma secretion (GO:0072643) | 8.23012306 |
2 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.75673380 |
3 | hemidesmosome assembly (GO:0031581) | 4.96419587 |
4 | folic acid transport (GO:0015884) | 4.58578487 |
5 | regulation of transforming growth factor beta2 production (GO:0032909) | 4.54943165 |
6 | low-density lipoprotein particle clearance (GO:0034383) | 4.42450115 |
7 | cellular response to interferon-alpha (GO:0035457) | 4.36577295 |
8 | amyloid precursor protein catabolic process (GO:0042987) | 4.12753864 |
9 | intestinal epithelial cell development (GO:0060576) | 4.04193656 |
10 | regulation of water loss via skin (GO:0033561) | 3.93634321 |
11 | type B pancreatic cell proliferation (GO:0044342) | 3.73509493 |
12 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.67835452 |
13 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.63732444 |
14 | establishment of skin barrier (GO:0061436) | 3.63426361 |
15 | amyloid precursor protein metabolic process (GO:0042982) | 3.62749642 |
16 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.56257370 |
17 | cell adhesion mediated by integrin (GO:0033627) | 3.56170330 |
18 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.53885390 |
19 | regulation of metalloenzyme activity (GO:0048552) | 3.53292347 |
20 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.48537743 |
21 | positive regulation of epidermal cell differentiation (GO:0045606) | 3.43218522 |
22 | positive regulation of heat generation (GO:0031652) | 3.42901970 |
23 | nuclear envelope reassembly (GO:0031468) | 3.41019712 |
24 | mitotic nuclear envelope reassembly (GO:0007084) | 3.41019712 |
25 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.39755863 |
26 | folic acid metabolic process (GO:0046655) | 3.36204017 |
27 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 3.35054916 |
28 | amino sugar catabolic process (GO:0046348) | 3.34710706 |
29 | regulation of hippo signaling (GO:0035330) | 3.33330940 |
30 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.32959615 |
31 | adhesion of symbiont to host (GO:0044406) | 3.29724938 |
32 | lung-associated mesenchyme development (GO:0060484) | 3.29420416 |
33 | epithelial cell-cell adhesion (GO:0090136) | 3.25748201 |
34 | wound healing, spreading of epidermal cells (GO:0035313) | 3.25493970 |
35 | positive regulation of epidermis development (GO:0045684) | 3.25019001 |
36 | protein autoprocessing (GO:0016540) | 3.22365114 |
37 | skin morphogenesis (GO:0043589) | 3.20129879 |
38 | polarized epithelial cell differentiation (GO:0030859) | 3.19535730 |
39 | protein retention in ER lumen (GO:0006621) | 3.17653475 |
40 | labyrinthine layer development (GO:0060711) | 3.13609842 |
41 | formation of translation preinitiation complex (GO:0001731) | 3.13215653 |
42 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.12568737 |
43 | androgen biosynthetic process (GO:0006702) | 3.12338323 |
44 | regulation of gonadotropin secretion (GO:0032276) | 3.12149451 |
45 | gap junction assembly (GO:0016264) | 3.10884058 |
46 | keratinocyte proliferation (GO:0043616) | 3.09241589 |
47 | * cyclooxygenase pathway (GO:0019371) | 3.08908096 |
48 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.08536989 |
49 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.08536989 |
50 | galactose catabolic process (GO:0019388) | 3.03419821 |
51 | mammary gland epithelial cell proliferation (GO:0033598) | 3.02687073 |
52 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.98556045 |
53 | regulation of epidermal growth factor-activated receptor activity (GO:0007176) | 2.98543213 |
54 | cytokine secretion (GO:0050663) | 2.95539993 |
55 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.93692710 |
56 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.92790328 |
57 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.92790328 |
58 | modulation by symbiont of host immune response (GO:0052553) | 2.92790328 |
59 | positive regulation by symbiont of host defense response (GO:0052509) | 2.92790328 |
60 | modulation by symbiont of host defense response (GO:0052031) | 2.92790328 |
61 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.92790328 |
62 | cellular copper ion homeostasis (GO:0006878) | 2.90381809 |
63 | estrogen biosynthetic process (GO:0006703) | 2.90246015 |
64 | regulation of fever generation (GO:0031620) | 2.88945075 |
65 | response to peptidoglycan (GO:0032494) | 2.87560977 |
66 | apoptotic cell clearance (GO:0043277) | 2.86224578 |
67 | desmosome organization (GO:0002934) | 2.85776400 |
68 | response to parathyroid hormone (GO:0071107) | 2.84814255 |
69 | GDP-mannose metabolic process (GO:0019673) | 2.84178823 |
70 | polyketide metabolic process (GO:0030638) | 2.82319785 |
71 | doxorubicin metabolic process (GO:0044598) | 2.82319785 |
72 | daunorubicin metabolic process (GO:0044597) | 2.82319785 |
73 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.81081057 |
74 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.79987866 |
75 | regulation of keratinocyte proliferation (GO:0010837) | 2.79701649 |
76 | cell-substrate adherens junction assembly (GO:0007045) | 2.79607851 |
77 | focal adhesion assembly (GO:0048041) | 2.79607851 |
78 | membrane raft organization (GO:0031579) | 2.79360827 |
79 | regulation of cardioblast differentiation (GO:0051890) | 2.77231877 |
80 | regulation of translational fidelity (GO:0006450) | 2.76741743 |
81 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.76107382 |
82 | multicellular organismal water homeostasis (GO:0050891) | 2.74064811 |
83 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.74026142 |
84 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.72663821 |
85 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.71314845 |
86 | regulation of translational termination (GO:0006449) | 2.71056322 |
87 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.68909878 |
88 | protein maturation by protein folding (GO:0022417) | 2.67321959 |
89 | positive regulation of hair follicle development (GO:0051798) | 2.66369401 |
90 | positive regulation of hair cycle (GO:0042635) | 2.66369401 |
91 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.65012707 |
92 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.64877353 |
93 | hypotonic response (GO:0006971) | 2.63994343 |
94 | modified amino acid transport (GO:0072337) | 2.63654041 |
95 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.63390053 |
96 | negative regulation of stem cell proliferation (GO:2000647) | 2.63234416 |
97 | glucocorticoid biosynthetic process (GO:0006704) | 2.62945530 |
98 | L-serine transport (GO:0015825) | 2.59625699 |
99 | response to interferon-alpha (GO:0035455) | 2.59126829 |
100 | ribosome assembly (GO:0042255) | 2.59030326 |
101 | membrane budding (GO:0006900) | 2.58782219 |
102 | mannose metabolic process (GO:0006013) | 2.58721105 |
103 | regulation of podosome assembly (GO:0071801) | 2.58521154 |
104 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.57306395 |
105 | morphogenesis of embryonic epithelium (GO:0016331) | 2.56417507 |
106 | protein hydroxylation (GO:0018126) | 2.55926919 |
107 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.55605509 |
108 | tRNA methylation (GO:0030488) | 2.55037263 |
109 | transcytosis (GO:0045056) | 2.54957864 |
110 | cellular response to arsenic-containing substance (GO:0071243) | 2.53015008 |
111 | activation of Rac GTPase activity (GO:0032863) | 2.51926065 |
112 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.51659174 |
113 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.51507598 |
114 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.50147338 |
115 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.50045235 |
116 | positive regulation of p38MAPK cascade (GO:1900745) | 2.48909509 |
117 | regulation of keratinocyte differentiation (GO:0045616) | 2.48759009 |
118 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.47653909 |
119 | proteasome assembly (GO:0043248) | 2.47055027 |
120 | norepinephrine metabolic process (GO:0042415) | 2.45183380 |
121 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.45067180 |
122 | endothelial cell chemotaxis (GO:0035767) | 2.44523738 |
123 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.44327289 |
124 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.43688263 |
125 | lung vasculature development (GO:0060426) | 2.43418174 |
126 | regulation of cholesterol storage (GO:0010885) | 2.42990539 |
127 | establishment of apical/basal cell polarity (GO:0035089) | 2.42597802 |
128 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 2.42169695 |
129 | wound healing, spreading of cells (GO:0044319) | 2.42142723 |
130 | ncRNA 3-end processing (GO:0043628) | 2.41431250 |
131 | Golgi transport vesicle coating (GO:0048200) | 2.41108327 |
132 | COPI coating of Golgi vesicle (GO:0048205) | 2.41108327 |
133 | hippo signaling (GO:0035329) | 2.40907218 |
134 | epidermis development (GO:0008544) | 2.40256963 |
135 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.39963067 |
136 | water homeostasis (GO:0030104) | 2.39892408 |
137 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.39538781 |
138 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.39502471 |
139 | protein localization to endosome (GO:0036010) | 2.39397702 |
140 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.38817184 |
141 | lung lobe morphogenesis (GO:0060463) | 2.38023975 |
142 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.37940338 |
143 | regulation of heat generation (GO:0031650) | 2.37378456 |
144 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.36733963 |
145 | response to vitamin D (GO:0033280) | 2.35825798 |
146 | response to manganese ion (GO:0010042) | 2.35544619 |
147 | fructose metabolic process (GO:0006000) | 2.35418600 |
148 | iron ion import (GO:0097286) | 2.35382498 |
149 | peptidyl-proline hydroxylation (GO:0019511) | 2.35343889 |
150 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.35041845 |
151 | skin development (GO:0043588) | 2.34710774 |
152 | blastocyst development (GO:0001824) | 2.34426271 |
153 | regulation of mitochondrial translation (GO:0070129) | 2.34267792 |
154 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.33956738 |
155 | hair cycle (GO:0042633) | 2.33880416 |
156 | molting cycle (GO:0042303) | 2.33880416 |
157 | keratinocyte development (GO:0003334) | 2.33346908 |
158 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.31160575 |
159 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.28206918 |
160 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.26402358 |
161 | cell-substrate junction assembly (GO:0007044) | 2.26248801 |
162 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.26215746 |
163 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.26215746 |
164 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.26215746 |
165 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.25925637 |
166 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.25838555 |
167 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.25331846 |
168 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.24452420 |
169 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.24452420 |
170 | endodermal cell differentiation (GO:0035987) | 2.23322093 |
171 | regulation of histone H3-K27 methylation (GO:0061085) | 2.22586125 |
172 | sphingosine metabolic process (GO:0006670) | 2.22420746 |
173 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 2.21702682 |
174 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.21417290 |
175 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.20715420 |
176 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.20715420 |
177 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.18808177 |
178 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.16651015 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 8.27491662 |
2 | * TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.77447308 |
3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.33586104 |
4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.87021756 |
5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.53405405 |
6 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.39939264 |
7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.38727708 |
8 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.36290041 |
9 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.29449532 |
10 | * TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.27387683 |
11 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.23153549 |
12 | * SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.21700248 |
13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.19911688 |
14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.19776749 |
15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.10867108 |
16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.09321450 |
17 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.03025509 |
18 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.02702931 |
19 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.94823425 |
20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.91236962 |
21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.88945369 |
22 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.84380423 |
23 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.84380423 |
24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.82920202 |
25 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.76218264 |
26 | * POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.75374582 |
27 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.75100830 |
28 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.72893466 |
29 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.70182234 |
30 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.70066714 |
31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.70038367 |
32 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.69006091 |
33 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.63978228 |
34 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.62970601 |
35 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.61834020 |
36 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.60073235 |
37 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.58510764 |
38 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.56786785 |
39 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.56074207 |
40 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.54355694 |
41 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.52904214 |
42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.52275202 |
43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.51565260 |
44 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.47000086 |
45 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.46412876 |
46 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.46222797 |
47 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.45348648 |
48 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.43846270 |
49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.43800678 |
50 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.43140389 |
51 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.43140389 |
52 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.43140389 |
53 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.42264934 |
54 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.41356936 |
55 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.39884002 |
56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.38493274 |
57 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.36947193 |
58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.35920918 |
59 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.31003465 |
60 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.30928082 |
61 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.30656668 |
62 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.30511147 |
63 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.29833434 |
64 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.29316943 |
65 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.29057862 |
66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28960577 |
67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28071530 |
68 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.27632127 |
69 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.27517071 |
70 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.27443762 |
71 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25192234 |
72 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.24438249 |
73 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.23976963 |
74 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.20940432 |
75 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.19787854 |
76 | * ELF5_23300383_ChIP-Seq_T47D_Human | 1.19282439 |
77 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.19179237 |
78 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.18899469 |
79 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.18808605 |
80 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.18697265 |
81 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.18617734 |
82 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.17717194 |
83 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.17322268 |
84 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.16856723 |
85 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.16465045 |
86 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.16427076 |
87 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.15293662 |
88 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.14156762 |
89 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.11519147 |
90 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.11512987 |
91 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11086249 |
92 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.11012959 |
93 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09720199 |
94 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.08469867 |
95 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.06803621 |
96 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.06685613 |
97 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.06247149 |
98 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.05742315 |
99 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.03995503 |
100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.03538662 |
101 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02702790 |
102 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01714575 |
103 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.00989046 |
104 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00796082 |
105 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.00765197 |
106 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.00757313 |
107 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00385289 |
108 | GATA1_22025678_ChIP-Seq_K562_Human | 1.00331238 |
109 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98752271 |
110 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.97971200 |
111 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97381029 |
112 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.97255353 |
113 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.96964860 |
114 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.96738656 |
115 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.96507935 |
116 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95402149 |
117 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.94729375 |
118 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.94265287 |
119 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.93943868 |
120 | * NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93663945 |
121 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.93181120 |
122 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.93119679 |
123 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91158218 |
124 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.90143709 |
125 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.89186258 |
126 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88540792 |
127 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.88386217 |
128 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.87886456 |
129 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.87696027 |
130 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.86931351 |
131 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86774176 |
132 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.86722906 |
133 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.86513848 |
134 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.85474027 |
135 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.84523034 |
136 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.84312921 |
137 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.84129080 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0008438_abnormal_cutaneous_collagen | 3.73416572 |
2 | MP0010352_gastrointestinal_tract_polyps | 3.33045791 |
3 | MP0005275_abnormal_skin_tensile | 3.24427305 |
4 | MP0000579_abnormal_nail_morphology | 3.09837626 |
5 | MP0003566_abnormal_cell_adhesion | 2.64234922 |
6 | MP0003705_abnormal_hypodermis_morpholog | 2.38755942 |
7 | MP0010234_abnormal_vibrissa_follicle | 2.35177423 |
8 | MP0004233_abnormal_muscle_weight | 2.26822232 |
9 | MP0002796_impaired_skin_barrier | 2.25433287 |
10 | MP0005023_abnormal_wound_healing | 2.24180505 |
11 | MP0009840_abnormal_foam_cell | 2.09270064 |
12 | MP0003693_abnormal_embryo_hatching | 2.02798322 |
13 | MP0005058_abnormal_lysosome_morphology | 1.97538667 |
14 | MP0001958_emphysema | 1.94726250 |
15 | MP0009053_abnormal_anal_canal | 1.89094541 |
16 | MP0002060_abnormal_skin_morphology | 1.85788197 |
17 | MP0001661_extended_life_span | 1.80397243 |
18 | MP0003303_peritoneal_inflammation | 1.76933941 |
19 | MP0004947_skin_inflammation | 1.72669134 |
20 | MP0000383_abnormal_hair_follicle | 1.72584072 |
21 | MP0003453_abnormal_keratinocyte_physiol | 1.72369106 |
22 | MP0002254_reproductive_system_inflammat | 1.72184545 |
23 | MP0001542_abnormal_bone_strength | 1.71466087 |
24 | MP0003941_abnormal_skin_development | 1.71035438 |
25 | MP0004272_abnormal_basement_membrane | 1.68601608 |
26 | MP0001216_abnormal_epidermal_layer | 1.66173752 |
27 | MP0005623_abnormal_meninges_morphology | 1.65285570 |
28 | MP0001756_abnormal_urination | 1.64694268 |
29 | MP0010678_abnormal_skin_adnexa | 1.64407842 |
30 | MP0000013_abnormal_adipose_tissue | 1.62574170 |
31 | MP0008260_abnormal_autophagy | 1.61821303 |
32 | MP0000427_abnormal_hair_cycle | 1.56992358 |
33 | MP0005076_abnormal_cell_differentiation | 1.54467818 |
34 | MP0003806_abnormal_nucleotide_metabolis | 1.54122262 |
35 | MP0000627_abnormal_mammary_gland | 1.48596816 |
36 | MP0004782_abnormal_surfactant_physiolog | 1.47706426 |
37 | MP0003191_abnormal_cellular_cholesterol | 1.47294015 |
38 | MP0010030_abnormal_orbit_morphology | 1.46132913 |
39 | MP0000678_abnormal_parathyroid_gland | 1.45759007 |
40 | MP0001533_abnormal_skeleton_physiology | 1.45375602 |
41 | MP0003186_abnormal_redox_activity | 1.42568585 |
42 | MP0000343_altered_response_to | 1.41209252 |
43 | MP0002234_abnormal_pharynx_morphology | 1.41123445 |
44 | MP0003448_altered_tumor_morphology | 1.40437134 |
45 | MP0005501_abnormal_skin_physiology | 1.39382515 |
46 | MP0005083_abnormal_biliary_tract | 1.37559121 |
47 | MP0004264_abnormal_extraembryonic_tissu | 1.36047634 |
48 | MP0008004_abnormal_stomach_pH | 1.35692174 |
49 | MP0003828_pulmonary_edema | 1.35046802 |
50 | MP0000750_abnormal_muscle_regeneration | 1.33683671 |
51 | MP0003300_gastrointestinal_ulcer | 1.30384833 |
52 | MP0004185_abnormal_adipocyte_glucose | 1.30227958 |
53 | MP0002098_abnormal_vibrissa_morphology | 1.26799271 |
54 | MP0009785_altered_susceptibility_to | 1.26655309 |
55 | MP0004957_abnormal_blastocyst_morpholog | 1.26515659 |
56 | MP0005666_abnormal_adipose_tissue | 1.26366580 |
57 | MP0003724_increased_susceptibility_to | 1.26276848 |
58 | MP0000003_abnormal_adipose_tissue | 1.25388691 |
59 | MP0002295_abnormal_pulmonary_circulatio | 1.25126998 |
60 | MP0000537_abnormal_urethra_morphology | 1.22668715 |
61 | MP0005164_abnormal_response_to | 1.21855316 |
62 | MP0001881_abnormal_mammary_gland | 1.19347546 |
63 | MP0009780_abnormal_chondrocyte_physiolo | 1.17478084 |
64 | MP0000566_synostosis | 1.15925487 |
65 | MP0003436_decreased_susceptibility_to | 1.14571705 |
66 | MP0002332_abnormal_exercise_endurance | 1.13072416 |
67 | MP0000377_abnormal_hair_follicle | 1.09584922 |
68 | MP0002166_altered_tumor_susceptibility | 1.08612863 |
69 | MP0003950_abnormal_plasma_membrane | 1.07861736 |
70 | MP0005451_abnormal_body_composition | 1.07415075 |
71 | MP0002006_tumorigenesis | 1.06703195 |
72 | MP0008875_abnormal_xenobiotic_pharmacok | 1.05471176 |
73 | MP0001348_abnormal_lacrimal_gland | 1.04022753 |
74 | MP0003111_abnormal_nucleus_morphology | 1.02382518 |
75 | MP0010386_abnormal_urinary_bladder | 1.01489286 |
76 | MP0000647_abnormal_sebaceous_gland | 0.99634124 |
77 | MP0006054_spinal_hemorrhage | 0.99250466 |
78 | MP0002998_abnormal_bone_remodeling | 0.99026925 |
79 | MP0003091_abnormal_cell_migration | 0.97646918 |
80 | MP0004019_abnormal_vitamin_homeostasis | 0.97523109 |
81 | MP0004858_abnormal_nervous_system | 0.97154633 |
82 | MP0005390_skeleton_phenotype | 0.97014155 |
83 | MP0005330_cardiomyopathy | 0.95851160 |
84 | MP0002168_other_aberrant_phenotype | 0.94949018 |
85 | MP0010771_integument_phenotype | 0.94524711 |
86 | MP0000858_altered_metastatic_potential | 0.93601582 |
87 | MP0003011_delayed_dark_adaptation | 0.93570260 |
88 | MP0005503_abnormal_tendon_morphology | 0.93460740 |
89 | MP0005197_abnormal_uvea_morphology | 0.92022722 |
90 | MP0000358_abnormal_cell_content/ | 0.91554158 |
91 | MP0003045_fibrosis | 0.91347373 |
92 | MP0005257_abnormal_intraocular_pressure | 0.91328209 |
93 | MP0005395_other_phenotype | 0.91296708 |
94 | MP0005375_adipose_tissue_phenotype | 0.90134763 |
95 | MP0003718_maternal_effect | 0.90065343 |
96 | MP0009278_abnormal_bone_marrow | 0.87816460 |
97 | MP0001919_abnormal_reproductive_system | 0.87494695 |
98 | MP0001191_abnormal_skin_condition | 0.84551393 |
99 | MP0003936_abnormal_reproductive_system | 0.84274856 |
100 | MP0002136_abnormal_kidney_physiology | 0.84091483 |
101 | MP0010155_abnormal_intestine_physiology | 0.82968823 |
102 | MP0003315_abnormal_perineum_morphology | 0.82615987 |
103 | MP0009931_abnormal_skin_appearance | 0.81514616 |
104 | MP0002877_abnormal_melanocyte_morpholog | 0.79906301 |
105 | MP0000733_abnormal_muscle_development | 0.79214144 |
106 | MP0003786_premature_aging | 0.79128527 |
107 | MP0005670_abnormal_white_adipose | 0.77952225 |
108 | MP0005508_abnormal_skeleton_morphology | 0.77901026 |
109 | MP0001849_ear_inflammation | 0.76843041 |
110 | MP0001340_abnormal_eyelid_morphology | 0.76741333 |
111 | MP0001243_abnormal_dermal_layer | 0.76647157 |
112 | MP0001727_abnormal_embryo_implantation | 0.76314008 |
113 | MP0005310_abnormal_salivary_gland | 0.75697303 |
114 | * MP0002419_abnormal_innate_immunity | 0.75694702 |
115 | MP0009643_abnormal_urine_homeostasis | 0.75464868 |
116 | MP0005025_abnormal_response_to | 0.74019746 |
117 | MP0000467_abnormal_esophagus_morphology | 0.73205094 |
118 | MP0008775_abnormal_heart_ventricle | 0.73201902 |
119 | MP0010307_abnormal_tumor_latency | 0.72642321 |
120 | MP0002876_abnormal_thyroid_physiology | 0.72269568 |
121 | MP0000367_abnormal_coat/_hair | 0.72093218 |
122 | MP0000762_abnormal_tongue_morphology | 0.70718155 |
123 | MP0002909_abnormal_adrenal_gland | 0.70201061 |
124 | MP0004381_abnormal_hair_follicle | 0.70141046 |
125 | MP0009764_decreased_sensitivity_to | 0.69554680 |
126 | MP0005166_decreased_susceptibility_to | 0.69398232 |
127 | MP0002896_abnormal_bone_mineralization | 0.69033202 |
128 | MP0001873_stomach_inflammation | 0.68951860 |
129 | MP0005397_hematopoietic_system_phenotyp | 0.68623210 |
130 | MP0001545_abnormal_hematopoietic_system | 0.68623210 |
131 | MP0003795_abnormal_bone_structure | 0.67552069 |
132 | MP0009250_abnormal_appendicular_skeleto | 0.66750230 |
133 | MP0009379_abnormal_foot_pigmentation | 0.66354494 |
134 | MP0002133_abnormal_respiratory_system | 0.65280350 |
135 | MP0000490_abnormal_crypts_of | 0.64494074 |
136 | MP0008932_abnormal_embryonic_tissue | 0.64406361 |
137 | MP0003755_abnormal_palate_morphology | 0.63226877 |
138 | MP0005193_abnormal_anterior_eye | 0.62135667 |
139 | MP0005165_increased_susceptibility_to | 0.61364632 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Premature rupture of membranes (HP:0001788) | 4.69894236 |
2 | Papilledema (HP:0001085) | 3.99287402 |
3 | Aortic aneurysm (HP:0004942) | 3.80501223 |
4 | Increased density of long bones (HP:0006392) | 3.74470379 |
5 | Facial diplegia (HP:0001349) | 3.67138734 |
6 | Hypotrichosis (HP:0001006) | 3.64856420 |
7 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 3.64670708 |
8 | Osteolytic defects of the hand bones (HP:0009699) | 3.64670708 |
9 | Atrophic scars (HP:0001075) | 3.56824705 |
10 | Aortic dissection (HP:0002647) | 3.40071752 |
11 | Ankle contracture (HP:0006466) | 3.29816714 |
12 | Thick nail (HP:0001805) | 3.15566937 |
13 | Hypoplasia of dental enamel (HP:0006297) | 3.13712229 |
14 | Protrusio acetabuli (HP:0003179) | 3.03448247 |
15 | Abnormality of glycolipid metabolism (HP:0010969) | 3.01761309 |
16 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.01761309 |
17 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.01761309 |
18 | Onycholysis (HP:0001806) | 3.01637500 |
19 | Abnormality of the distal phalanges of the toes (HP:0010182) | 3.00810259 |
20 | Alopecia of scalp (HP:0002293) | 3.00609269 |
21 | Brittle hair (HP:0002299) | 2.98557697 |
22 | Abnormal hair laboratory examination (HP:0003328) | 2.98319017 |
23 | Cervical subluxation (HP:0003308) | 2.96475573 |
24 | Short nail (HP:0001799) | 2.93031217 |
25 | Increased cerebral lipofuscin (HP:0011813) | 2.87602000 |
26 | Milia (HP:0001056) | 2.87377066 |
27 | Interstitial pulmonary disease (HP:0006530) | 2.83831588 |
28 | Reduced subcutaneous adipose tissue (HP:0003758) | 2.80765004 |
29 | Vacuolated lymphocytes (HP:0001922) | 2.78116048 |
30 | Myopathic facies (HP:0002058) | 2.76545746 |
31 | Abnormality of macrophages (HP:0004311) | 2.75409255 |
32 | Right ventricular cardiomyopathy (HP:0011663) | 2.72507565 |
33 | Fragile nails (HP:0001808) | 2.72048620 |
34 | Vertebral compression fractures (HP:0002953) | 2.69070217 |
35 | Amelogenesis imperfecta (HP:0000705) | 2.68726885 |
36 | Pustule (HP:0200039) | 2.68222278 |
37 | Pili torti (HP:0003777) | 2.61956225 |
38 | Abnormality of the umbilical cord (HP:0010881) | 2.57396359 |
39 | Plantar hyperkeratosis (HP:0007556) | 2.53005854 |
40 | Eczematoid dermatitis (HP:0000976) | 2.50823139 |
41 | Spinal cord compression (HP:0002176) | 2.49489421 |
42 | Distal lower limb muscle weakness (HP:0009053) | 2.47464943 |
43 | Ureteral duplication (HP:0000073) | 2.44529662 |
44 | Renal tubular acidosis (HP:0001947) | 2.44036418 |
45 | Nail dystrophy (HP:0008404) | 2.43712495 |
46 | Ridged nail (HP:0001807) | 2.42316973 |
47 | Trismus (HP:0000211) | 2.40875130 |
48 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.38710982 |
49 | Broad face (HP:0000283) | 2.37658672 |
50 | Follicular hyperkeratosis (HP:0007502) | 2.36838918 |
51 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.34849213 |
52 | Tetraparesis (HP:0002273) | 2.34813615 |
53 | Advanced eruption of teeth (HP:0006288) | 2.33861603 |
54 | Entropion (HP:0000621) | 2.33557276 |
55 | Abnormality of nail color (HP:0100643) | 2.32116961 |
56 | Pterygium (HP:0001059) | 2.30022845 |
57 | Distal lower limb amyotrophy (HP:0008944) | 2.26625580 |
58 | Hypokinesia (HP:0002375) | 2.26531924 |
59 | Shallow orbits (HP:0000586) | 2.24332149 |
60 | Acanthosis nigricans (HP:0000956) | 2.19930495 |
61 | Blepharitis (HP:0000498) | 2.19587850 |
62 | Prolonged neonatal jaundice (HP:0006579) | 2.19511945 |
63 | Tibial bowing (HP:0002982) | 2.19384642 |
64 | Congenital, generalized hypertrichosis (HP:0004540) | 2.19324854 |
65 | Fused cervical vertebrae (HP:0002949) | 2.19024521 |
66 | Abnormal trabecular bone morphology (HP:0100671) | 2.16305387 |
67 | Bowed forearm bones (HP:0003956) | 2.14972215 |
68 | Bowing of the arm (HP:0006488) | 2.14972215 |
69 | Elbow flexion contracture (HP:0002987) | 2.14370448 |
70 | Ileus (HP:0002595) | 2.13631556 |
71 | Progressive visual loss (HP:0000529) | 2.10990147 |
72 | Choanal stenosis (HP:0000452) | 2.10626266 |
73 | Partial agenesis of the corpus callosum (HP:0001338) | 2.08474151 |
74 | Cerebral aneurysm (HP:0004944) | 2.06389400 |
75 | Ulnar bowing (HP:0003031) | 2.06182388 |
76 | Dry hair (HP:0011359) | 2.05657019 |
77 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.04911708 |
78 | Abnormal blistering of the skin (HP:0008066) | 2.04843869 |
79 | Myocardial infarction (HP:0001658) | 2.03639089 |
80 | Difficulty climbing stairs (HP:0003551) | 2.03393908 |
81 | Sparse eyelashes (HP:0000653) | 1.99979771 |
82 | Mitral stenosis (HP:0001718) | 1.99756769 |
83 | Increased connective tissue (HP:0009025) | 1.99207668 |
84 | Dilatation of the ascending aorta (HP:0005111) | 1.98304420 |
85 | Selective tooth agenesis (HP:0001592) | 1.97655339 |
86 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.97288240 |
87 | Aplasia of the phalanges of the hand (HP:0009802) | 1.97288240 |
88 | Aplasia involving bones of the extremities (HP:0009825) | 1.97288240 |
89 | Focal segmental glomerulosclerosis (HP:0000097) | 1.97140931 |
90 | Abnormality of carpal bone ossification (HP:0006257) | 1.95501530 |
91 | Hematochezia (HP:0002573) | 1.94206314 |
92 | Soft skin (HP:0000977) | 1.94057757 |
93 | Achilles tendon contracture (HP:0001771) | 1.94053949 |
94 | Palmoplantar hyperkeratosis (HP:0000972) | 1.93141245 |
95 | Coxa vara (HP:0002812) | 1.92931218 |
96 | Type 1 muscle fiber predominance (HP:0003803) | 1.92230783 |
97 | Peritonitis (HP:0002586) | 1.91922434 |
98 | Glomerulosclerosis (HP:0000096) | 1.90957776 |
99 | Oligodontia (HP:0000677) | 1.89814003 |
100 | Fibular aplasia (HP:0002990) | 1.89591561 |
101 | Nausea (HP:0002018) | 1.88844536 |
102 | Wormian bones (HP:0002645) | 1.88623956 |
103 | Systemic lupus erythematosus (HP:0002725) | 1.88192712 |
104 | Natal tooth (HP:0000695) | 1.88126735 |
105 | Aplasia cutis congenita (HP:0001057) | 1.87888535 |
106 | Fragile skin (HP:0001030) | 1.87836385 |
107 | Rough bone trabeculation (HP:0100670) | 1.87775638 |
108 | Popliteal pterygium (HP:0009756) | 1.87530597 |
109 | Hand muscle atrophy (HP:0009130) | 1.86954946 |
110 | Patent foramen ovale (HP:0001655) | 1.86844222 |
111 | Relative macrocephaly (HP:0004482) | 1.86513647 |
112 | Broad ribs (HP:0000885) | 1.86065443 |
113 | Prostate neoplasm (HP:0100787) | 1.85543367 |
114 | Cardiovascular calcification (HP:0011915) | 1.85439909 |
115 | Stenosis of the external auditory canal (HP:0000402) | 1.84856790 |
116 | Hypoplasia of the uterus (HP:0000013) | 1.84474254 |
117 | Radial bowing (HP:0002986) | 1.84455782 |
118 | Flattened epiphyses (HP:0003071) | 1.84393885 |
119 | Breast hypoplasia (HP:0003187) | 1.83984226 |
120 | Flat acetabular roof (HP:0003180) | 1.83559708 |
121 | Aplasia/Hypoplasia of the clavicles (HP:0006710) | 1.82998746 |
122 | Aneurysm (HP:0002617) | 1.82803553 |
123 | Lip pit (HP:0100267) | 1.82770704 |
124 | Poikiloderma (HP:0001029) | 1.82293462 |
125 | Palmar hyperkeratosis (HP:0010765) | 1.81217463 |
126 | Erythema (HP:0010783) | 1.81187326 |
127 | Hyperacusis (HP:0010780) | 1.81162921 |
128 | Vascular calcification (HP:0004934) | 1.80178857 |
129 | Esophageal varix (HP:0002040) | 1.79637527 |
130 | Short hallux (HP:0010109) | 1.79494545 |
131 | Micronodular cirrhosis (HP:0001413) | 1.79242780 |
132 | Short clavicles (HP:0000894) | 1.79034312 |
133 | Deviation of the thumb (HP:0009603) | 1.75367180 |
134 | Spinal muscular atrophy (HP:0007269) | 1.75346027 |
135 | Spinal rigidity (HP:0003306) | 1.74990846 |
136 | Dysostosis multiplex (HP:0000943) | 1.74779494 |
137 | Nemaline bodies (HP:0003798) | 1.74240840 |
138 | Glucose intolerance (HP:0000833) | 1.74012379 |
139 | Renal salt wasting (HP:0000127) | 1.73894454 |
140 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.73812364 |
141 | Abnormal umbilical cord blood vessels (HP:0011403) | 1.72990303 |
142 | Single umbilical artery (HP:0001195) | 1.72990303 |
143 | Abnormality of the fetal cardiovascular system (HP:0010948) | 1.72990303 |
144 | Long foot (HP:0001833) | 1.72878437 |
145 | Premature loss of primary teeth (HP:0006323) | 1.72631750 |
146 | Abnormal ossification of hand bones (HP:0005921) | 1.72490578 |
147 | Hypoplastic pelvis (HP:0008839) | 1.70769290 |
148 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.70394312 |
149 | Abnormality of molar (HP:0011077) | 1.70008320 |
150 | Abnormality of molar morphology (HP:0011070) | 1.70008320 |
151 | Anorexia (HP:0002039) | 1.69877900 |
152 | Woolly hair (HP:0002224) | 1.69738250 |
153 | Gastrointestinal dysmotility (HP:0002579) | 1.69668395 |
154 | Concave nail (HP:0001598) | 1.69158471 |
155 | Ankyloglossia (HP:0010296) | 1.68768494 |
156 | Hydroxyprolinuria (HP:0003080) | 1.68222638 |
157 | Abnormality of proline metabolism (HP:0010907) | 1.68222638 |
158 | Small epiphyses (HP:0010585) | 1.68164908 |
159 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.67400164 |
160 | Tongue fasciculations (HP:0001308) | 1.67370307 |
161 | Cheilitis (HP:0100825) | 1.66189279 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA2 | 7.17069781 |
2 | IRAK3 | 3.46451372 |
3 | MYLK | 2.64690549 |
4 | WEE1 | 2.55151584 |
5 | TRIB3 | 2.51951249 |
6 | ERN1 | 2.48896102 |
7 | MAP3K3 | 2.23780152 |
8 | BUB1 | 2.19093109 |
9 | WNK4 | 2.12949314 |
10 | NME2 | 2.04915275 |
11 | STK39 | 1.99759833 |
12 | FER | 1.92301630 |
13 | MST4 | 1.91526631 |
14 | EPHA3 | 1.78359756 |
15 | MST1R | 1.71709126 |
16 | NTRK1 | 1.71053305 |
17 | TTN | 1.70380288 |
18 | AKT3 | 1.69897881 |
19 | FLT3 | 1.68206459 |
20 | LIMK1 | 1.67302772 |
21 | FRK | 1.62887236 |
22 | PIM2 | 1.53352229 |
23 | CAMK1D | 1.50322408 |
24 | DDR2 | 1.48873425 |
25 | TBK1 | 1.46964366 |
26 | MAP3K12 | 1.46851482 |
27 | PNCK | 1.45428295 |
28 | LATS1 | 1.43017125 |
29 | EPHB1 | 1.36958057 |
30 | RPS6KA4 | 1.35075560 |
31 | NLK | 1.33028003 |
32 | NME1 | 1.32057160 |
33 | RPS6KB2 | 1.28812615 |
34 | TESK1 | 1.24804149 |
35 | STK38 | 1.16605347 |
36 | LRRK2 | 1.11112002 |
37 | NEK9 | 1.10948429 |
38 | PDK2 | 1.09536183 |
39 | PAK4 | 1.08519537 |
40 | TSSK6 | 1.08475947 |
41 | SIK1 | 1.05566046 |
42 | STK3 | 1.04569513 |
43 | STK38L | 1.03402190 |
44 | MET | 1.03283148 |
45 | FGFR4 | 1.01801238 |
46 | ERBB4 | 1.01191683 |
47 | TYK2 | 0.98811240 |
48 | ZAP70 | 0.98565485 |
49 | BLK | 0.98402990 |
50 | VRK2 | 0.96893709 |
51 | NUAK1 | 0.96789146 |
52 | OXSR1 | 0.96543703 |
53 | PIK3CG | 0.96380197 |
54 | MAP3K9 | 0.96163506 |
55 | SMG1 | 0.95872834 |
56 | BRAF | 0.95642225 |
57 | PRPF4B | 0.94525951 |
58 | MUSK | 0.94289882 |
59 | PAK1 | 0.94036230 |
60 | EPHB2 | 0.93995769 |
61 | ZAK | 0.92493620 |
62 | PAK2 | 0.89022346 |
63 | BRSK2 | 0.87819305 |
64 | LATS2 | 0.87734920 |
65 | TTK | 0.87249197 |
66 | IKBKB | 0.86399556 |
67 | LMTK2 | 0.84654411 |
68 | MAP3K6 | 0.84579324 |
69 | EIF2AK1 | 0.84149978 |
70 | ICK | 0.83451259 |
71 | DMPK | 0.83242255 |
72 | BMX | 0.83204997 |
73 | RIPK1 | 0.81846064 |
74 | ILK | 0.81514558 |
75 | IKBKE | 0.80021162 |
76 | MAP3K11 | 0.77064186 |
77 | JAK3 | 0.74715036 |
78 | PDK3 | 0.74442633 |
79 | PDK4 | 0.74442633 |
80 | TESK2 | 0.73755822 |
81 | STK24 | 0.72691010 |
82 | PRKCI | 0.70745295 |
83 | MAP2K3 | 0.70491730 |
84 | PIM1 | 0.67552978 |
85 | MAP2K2 | 0.67280789 |
86 | PTK6 | 0.66839036 |
87 | PBK | 0.66427747 |
88 | MAPKAPK3 | 0.65731743 |
89 | IRAK4 | 0.64323555 |
90 | SCYL2 | 0.62821674 |
91 | AURKA | 0.62369558 |
92 | CAMK2G | 0.62292175 |
93 | ARAF | 0.61863829 |
94 | PTK2 | 0.61474017 |
95 | TRPM7 | 0.61197178 |
96 | PDGFRA | 0.61170709 |
97 | ABL2 | 0.59649223 |
98 | NEK1 | 0.59104154 |
99 | MAP3K2 | 0.58247401 |
100 | EIF2AK3 | 0.57641647 |
101 | STK10 | 0.57538626 |
102 | AURKB | 0.57330731 |
103 | MAP3K14 | 0.57266885 |
104 | KDR | 0.57121431 |
105 | TAOK1 | 0.55887822 |
106 | PRKD2 | 0.55828743 |
107 | GSK3A | 0.55798765 |
108 | STK16 | 0.55515589 |
109 | CDK8 | 0.55190311 |
110 | EIF2AK2 | 0.54804024 |
111 | MAP2K1 | 0.54498740 |
112 | TAOK2 | 0.54124673 |
113 | BRSK1 | 0.54107767 |
114 | PHKG1 | 0.53947776 |
115 | PHKG2 | 0.53947776 |
116 | NEK2 | 0.53636759 |
117 | JAK1 | 0.53468270 |
118 | ALK | 0.51189852 |
119 | FGFR3 | 0.50611770 |
120 | PDGFRB | 0.50000598 |
121 | MAP3K8 | 0.49927044 |
122 | CHUK | 0.48244778 |
123 | MAPKAPK2 | 0.48109902 |
124 | DAPK3 | 0.47897388 |
125 | MTOR | 0.47379959 |
126 | CDK6 | 0.46836657 |
127 | PRKG2 | 0.45840885 |
128 | IRAK1 | 0.45300785 |
129 | CAMK1G | 0.44866850 |
130 | CSK | 0.44467130 |
131 | ADRBK1 | 0.42612222 |
132 | MAPKAPK5 | 0.42553386 |
133 | CDK7 | 0.41758176 |
134 | TGFBR2 | 0.41465482 |
135 | GRK5 | 0.40657536 |
136 | AKT2 | 0.39569941 |
137 | CAMK2D | 0.35134142 |
138 | CDC42BPA | 0.33586669 |
139 | MAP2K7 | 0.33081716 |
140 | CAMK2B | 0.32550976 |
141 | BCKDK | 0.31883616 |
142 | RAF1 | 0.31450356 |
143 | PKN2 | 0.29074114 |
144 | PLK1 | 0.27588171 |
145 | SIK3 | 0.25720566 |
146 | MELK | 0.25704777 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 3.89677193 |
2 | Sulfur relay system_Homo sapiens_hsa04122 | 2.36125522 |
3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.31704749 |
4 | Lysosome_Homo sapiens_hsa04142 | 2.25632087 |
5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.22732493 |
6 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.19846704 |
7 | Legionellosis_Homo sapiens_hsa05134 | 2.05016111 |
8 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.89228723 |
9 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.86997979 |
10 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.85994212 |
11 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.80194928 |
12 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.78457766 |
13 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.75294807 |
14 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.68447888 |
15 | Leishmaniasis_Homo sapiens_hsa05140 | 1.68185715 |
16 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.67468698 |
17 | Malaria_Homo sapiens_hsa05144 | 1.65824437 |
18 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.63812294 |
19 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.60129799 |
20 | Other glycan degradation_Homo sapiens_hsa00511 | 1.59178494 |
21 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.57436089 |
22 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.53180125 |
23 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.52256893 |
24 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.51603748 |
25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.50770549 |
26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.50031559 |
27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48987648 |
28 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.47326976 |
29 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.42364619 |
30 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.42222839 |
31 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.40436042 |
32 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39033627 |
33 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.37144501 |
34 | Focal adhesion_Homo sapiens_hsa04510 | 1.36755533 |
35 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.36543314 |
36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.36363890 |
37 | Amoebiasis_Homo sapiens_hsa05146 | 1.34660734 |
38 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.33650638 |
39 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.32735306 |
40 | Shigellosis_Homo sapiens_hsa05131 | 1.32307276 |
41 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32169131 |
42 | Mineral absorption_Homo sapiens_hsa04978 | 1.30370060 |
43 | Pertussis_Homo sapiens_hsa05133 | 1.29239050 |
44 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.28981486 |
45 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.28220209 |
46 | Adherens junction_Homo sapiens_hsa04520 | 1.26810337 |
47 | Ribosome_Homo sapiens_hsa03010 | 1.26738752 |
48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.26508737 |
49 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.25814737 |
50 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.25322956 |
51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24125113 |
52 | Thyroid cancer_Homo sapiens_hsa05216 | 1.23739655 |
53 | Tight junction_Homo sapiens_hsa04530 | 1.18281855 |
54 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.15779580 |
55 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.13380055 |
56 | Influenza A_Homo sapiens_hsa05164 | 1.11503825 |
57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11035895 |
58 | Hepatitis C_Homo sapiens_hsa05160 | 1.10900210 |
59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.09578539 |
60 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.09150220 |
61 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.08849752 |
62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07803911 |
63 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.07074531 |
64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.06938531 |
65 | Apoptosis_Homo sapiens_hsa04210 | 1.06269150 |
66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.05434738 |
67 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.03545263 |
68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.02902820 |
69 | Tuberculosis_Homo sapiens_hsa05152 | 1.00100020 |
70 | RNA polymerase_Homo sapiens_hsa03020 | 0.97770571 |
71 | Base excision repair_Homo sapiens_hsa03410 | 0.97691319 |
72 | Phagosome_Homo sapiens_hsa04145 | 0.97439349 |
73 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.96492863 |
74 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.95731510 |
75 | Salmonella infection_Homo sapiens_hsa05132 | 0.95145401 |
76 | Bladder cancer_Homo sapiens_hsa05219 | 0.94777090 |
77 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.94379838 |
78 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.93993818 |
79 | RNA transport_Homo sapiens_hsa03013 | 0.91038935 |
80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.89532506 |
81 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.89503813 |
82 | * Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88493569 |
83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.86686314 |
84 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.84916069 |
85 | Measles_Homo sapiens_hsa05162 | 0.84061430 |
86 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.83847150 |
87 | Prostate cancer_Homo sapiens_hsa05215 | 0.82613872 |
88 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.82387208 |
89 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.81619490 |
90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.81401637 |
91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80892902 |
92 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.80620583 |
93 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.79670105 |
94 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.79292088 |
95 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.78904306 |
96 | DNA replication_Homo sapiens_hsa03030 | 0.78860905 |
97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.78440247 |
98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78228316 |
99 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.77930265 |
100 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77147523 |
101 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76735819 |
102 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76607510 |
103 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74703526 |
104 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.69506014 |
105 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69395977 |
106 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68554042 |
107 | Endocytosis_Homo sapiens_hsa04144 | 0.67417912 |
108 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.67030183 |
109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.66710483 |
110 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.66406270 |
111 | Huntingtons disease_Homo sapiens_hsa05016 | 0.65744539 |
112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.65661753 |
113 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.65004399 |
114 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62189663 |
115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.61238335 |
116 | Alzheimers disease_Homo sapiens_hsa05010 | 0.59758470 |
117 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.59317411 |
118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.59251437 |
119 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.59118839 |
120 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.56472260 |
121 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.56169704 |
122 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55863616 |
123 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.55838629 |
124 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.55022793 |
125 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.54899028 |
126 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.53842890 |
127 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53484335 |
128 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.52398299 |
129 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.52354595 |
130 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.52105662 |
131 | HTLV-I infection_Homo sapiens_hsa05166 | 0.51480587 |
132 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50356565 |
133 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.50046866 |
134 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48761339 |
135 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.48281015 |
136 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47919417 |
137 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47483576 |
138 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.47400453 |
139 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47388112 |
140 | Insulin resistance_Homo sapiens_hsa04931 | 0.47317704 |
141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47251880 |
142 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.47194172 |
143 | Parkinsons disease_Homo sapiens_hsa05012 | 0.46664104 |
144 | Hepatitis B_Homo sapiens_hsa05161 | 0.45651751 |
145 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.44873206 |
146 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.44681469 |
147 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.44275132 |
148 | Mismatch repair_Homo sapiens_hsa03430 | 0.43703802 |
149 | Homologous recombination_Homo sapiens_hsa03440 | 0.43135169 |
150 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.40926859 |
151 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37111280 |
152 | Basal transcription factors_Homo sapiens_hsa03022 | 0.36982476 |
153 | Purine metabolism_Homo sapiens_hsa00230 | 0.36703666 |
154 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.36581959 |
155 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35850361 |